Andrew Cooper
Stock Analyst at Raymond James
(1.96)
# 2,725
Out of 4,808 analysts
134
Total ratings
41.53%
Success rate
-1.79%
Average return
Main Sectors:
Stocks Rated by Andrew Cooper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ITGR Integer Holdings | Initiates: Outperform | $145 | $116.50 | +24.46% | 1 | Mar 28, 2025 | |
| UFPT UFP Technologies | Initiates: Market Perform | n/a | $209.42 | - | 1 | Mar 28, 2025 | |
| MYGN Myriad Genetics | Reiterates: Outperform | $27 → $19 | $8.00 | +137.50% | 4 | Feb 25, 2025 | |
| GH Guardant Health | Reiterates: Outperform | $39 → $59 | $43.71 | +34.98% | 3 | Feb 21, 2025 | |
| AVTR Avantor | Reiterates: Outperform | $26 → $24 | $15.22 | +57.69% | 14 | Feb 10, 2025 | |
| HAE Haemonetics | Reiterates: Strong Buy | $120 → $115 | $60.04 | +91.54% | 8 | Feb 7, 2025 | |
| HOLX Hologic | Reiterates: Outperform | $95 → $90 | $57.85 | +55.57% | 11 | Feb 6, 2025 | |
| TMO Thermo Fisher Scientific | Reiterates: Outperform | $650 → $667 | $438.15 | +52.23% | 6 | Feb 3, 2025 | |
| RVTY Revvity | Reiterates: Outperform | $140 → $145 | $94.86 | +52.86% | 7 | Feb 3, 2025 | |
| DHR Danaher | Downgrades: Market Perform | n/a | $188.73 | - | 8 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $44.45 | - | 8 | Sep 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $18.81 | - | 16 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Outperform | $68 → $85 | $148.04 | -42.58% | 5 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Outperform | $100 → $76 | $26.91 | +182.42% | 12 | Feb 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $3.71 | - | 1 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $26.71 | - | 1 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $9.32 | - | 14 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $31.80 | - | 8 | Jan 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $45 | $19.00 | +136.84% | 1 | Nov 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $2.93 | - | 5 | Sep 22, 2021 | |
Integer Holdings
Mar 28, 2025
Initiates: Outperform
Price Target: $145
Current: $116.50
Upside: +24.46%
UFP Technologies
Mar 28, 2025
Initiates: Market Perform
Price Target: n/a
Current: $209.42
Upside: -
Myriad Genetics
Feb 25, 2025
Reiterates: Outperform
Price Target: $27 → $19
Current: $8.00
Upside: +137.50%
Guardant Health
Feb 21, 2025
Reiterates: Outperform
Price Target: $39 → $59
Current: $43.71
Upside: +34.98%
Avantor
Feb 10, 2025
Reiterates: Outperform
Price Target: $26 → $24
Current: $15.22
Upside: +57.69%
Haemonetics
Feb 7, 2025
Reiterates: Strong Buy
Price Target: $120 → $115
Current: $60.04
Upside: +91.54%
Hologic
Feb 6, 2025
Reiterates: Outperform
Price Target: $95 → $90
Current: $57.85
Upside: +55.57%
Thermo Fisher Scientific
Feb 3, 2025
Reiterates: Outperform
Price Target: $650 → $667
Current: $438.15
Upside: +52.23%
Revvity
Feb 3, 2025
Reiterates: Outperform
Price Target: $140 → $145
Current: $94.86
Upside: +52.86%
Danaher
Feb 3, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $188.73
Upside: -
Sep 26, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $44.45
Upside: -
May 13, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $18.81
Upside: -
Feb 20, 2024
Downgrades: Outperform
Price Target: $68 → $85
Current: $148.04
Upside: -42.58%
Feb 14, 2024
Downgrades: Outperform
Price Target: $100 → $76
Current: $26.91
Upside: +182.42%
Jul 19, 2023
Initiates: Market Perform
Price Target: n/a
Current: $3.71
Upside: -
Jul 19, 2023
Initiates: Market Perform
Price Target: n/a
Current: $26.71
Upside: -
May 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $9.32
Upside: -
Jan 18, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $31.80
Upside: -
Nov 18, 2022
Initiates: Outperform
Price Target: $45
Current: $19.00
Upside: +136.84%
Sep 22, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $2.93
Upside: -